Patent ID: 9567367
Date: 2017-02-14
CPC Classifications: A61K,A61P,C07K,Y02A

Claim:
1. A method for treating a bacterial infection in a human patient and any acute inflammation associated therewith, which bacterial infection is with at least one bacteria selected from the group consisting of Gram-positive bacteria or Gram-negative bacteria, said method comprising a single administration, within a seven day period from said single administration to said patient, at a suitable time following said infection, one single dose of a therapeutically effective amount of a peptide consisting of the amino acid sequence SPMLVAYD as denoted by SEQ ID NO:1, also denoted as p2TA, or a peptide consisting of the amino acid sequence (D-A)SPMLVAYD(D-A) as denoted by SEQ ID NO:2, also denoted as D-Ala p2TA, or a salt or ester of any of said peptides, or a pharmaceutical composition comprising the same, wherein said therapeutically effective amount is from about 0.1 to about 1 mg peptide/kg body weight of the human patient.